These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15845832)

  • 1. A lupus drug and FDA approval.
    Merrill JT; Raymond S
    Science; 2005 Apr; 308(5721):497; author reply 497. PubMed ID: 15845832
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug development. Lupus drug company asks FDA for second chance.
    Couzin J
    Science; 2005 Feb; 307(5711):835. PubMed ID: 15705822
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of an FDA guidance document for clinical trials in SLE.
    Siegel JN
    Lupus; 1999; 8(8):581-5. PubMed ID: 10568893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA slow to encourage lupus drugs.
    Webber D
    Nat Biotechnol; 1999 Apr; 17(4):319. PubMed ID: 10207867
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA to act on benlysta, rare new drug for lupus.
    Morrow T
    Manag Care; 2011 Jan; 20(1):43-4. PubMed ID: 21309405
    [No Abstract]   [Full Text] [Related]  

  • 6. Ending the 50-year drought of FDA drug approval for SLE.
    Merrill JT
    Bull NYU Hosp Jt Dis; 2011; 69(3):238-42. PubMed ID: 22035436
    [No Abstract]   [Full Text] [Related]  

  • 7. A critical review of clinical trials in systemic lupus erythematosus.
    Mahieu MA; Strand V; Simon LS; Lipsky PE; Ramsey-Goldman R
    Lupus; 2016 Sep; 25(10):1122-40. PubMed ID: 27497257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abetimus sodium: a medication for the prevention of lupus nephritis flares.
    Horowitz DM; Furie RA
    Expert Opin Pharmacother; 2009 Jun; 10(9):1501-7. PubMed ID: 19505217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Landmark lupus approval opens door for next wave of drugs.
    Nat Rev Drug Discov; 2011 Apr; 10(4):243-5. PubMed ID: 21455222
    [No Abstract]   [Full Text] [Related]  

  • 10. Abetimus (La Jolla pharmaceuticals).
    Lorenz HM
    Curr Opin Investig Drugs; 2002 Feb; 3(2):234-9. PubMed ID: 12020052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine (CsA) in lupus nephritis: assessing the evidence.
    Moroni G; Doria A; Ponticelli C
    Nephrol Dial Transplant; 2009 Jan; 24(1):15-20. PubMed ID: 18852191
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene therapy briefs.
    Philippidis A
    Hum Gene Ther; 2012 Dec; 23(12):1221-3. PubMed ID: 23234557
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment for lupus, first in 50 years, offers modest benefits, hope to patients.
    Mitka M
    JAMA; 2011 May; 305(17):1754-5. PubMed ID: 21540415
    [No Abstract]   [Full Text] [Related]  

  • 14. LJP 394 (abetimus sodium, Riquent) in the management of systemic lupus erythematosus.
    Wallace DJ; Tumlin JA
    Lupus; 2004; 13(5):323-7. PubMed ID: 15230286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What was wrong and might now go right with clinical trials for lupus?
    Merrill JT
    Curr Rheumatol Rep; 2009 Aug; 11(4):235-7. PubMed ID: 19691925
    [No Abstract]   [Full Text] [Related]  

  • 16. Bullous systemic lupus erythematosus induced by the therapy for lupus nephritis.
    Jedlickova H; Bohmová J; Sirotkova A
    Int J Dermatol; 2008 Dec; 47(12):1315-6. PubMed ID: 19126028
    [No Abstract]   [Full Text] [Related]  

  • 17. Abetimus sodium (riquent) for the prevention of nephritic flares in patients with systemic lupus erythematosus.
    Furie R
    Rheum Dis Clin North Am; 2006 Feb; 32(1):149-56, x. PubMed ID: 16504827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New treatments for systemic diseases].
    Bader-Meunier B; Willems M
    Arch Pediatr; 2006 Jun; 13(6):596-8. PubMed ID: 16690273
    [No Abstract]   [Full Text] [Related]  

  • 19. Methotrexate benefits in patients with lupus with and without nephritis.
    Ferraccioli GF; De Vita S; Bartoli E
    J Rheumatol; 1995 Jul; 22(7):1442. PubMed ID: 7562799
    [No Abstract]   [Full Text] [Related]  

  • 20. New clinical trials policy at FDA.
    Vastag B
    Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.